Terms: = Lymphoma AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12 AND Diagnosis
33 results:
1. 2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
[TBL] [Abstract] [Full Text] [Related]
2. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract] [Full Text] [Related]
3. A novel TPD52L2-ROS1 gene fusion expanding the molecular alterations in inflammatory myofibroblastic tumor: case report and literature review.
Liu X; Duan Y; Wang G; Zhu P
Diagn Pathol; 2023 Sep; 18(1):105. PubMed ID: 37735390
[TBL] [Abstract] [Full Text] [Related]
4. Trends in Survival Rates of Non-Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
Chi SA; Yu H; Choi YL; Park S; Sun JM; Lee SH; Ahn JS; Ahn MJ; Choi DH; Kim K; Jung HA; Park K
JAMA Netw Open; 2023 Mar; 6(3):e232002. PubMed ID: 36929402
[TBL] [Abstract] [Full Text] [Related]
5. Advances in the diagnosis and Treatment of a Driving Target: ret Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China.
Li T; Yang WY; Liu TT; Li Y; Liu L; Zheng X; Zhao L; Zhang F; Hu Y
Technol Cancer Res Treat; 2023; 22():15330338221148802. PubMed ID: 36628459
[TBL] [Abstract] [Full Text] [Related]
6. Histopathologic and Molecular Characterization of Uterine Leiomyoma-like Inflammatory Myofibroblastic Tumor: Comparison to Molecular Subtypes of Uterine Leiomyoma.
Kuisma H; Jokinen V; Pasanen A; Heikinheimo O; Karhu A; Välimäki N; Aaltonen L; Bützow R
Am J Surg Pathol; 2022 Aug; 46(8):1126-1136. PubMed ID: 35426837
[TBL] [Abstract] [Full Text] [Related]
7. Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement.
Krawczyk P; Grenda A; Terlecka P; Błach J; Wojas-Krawczyk K; Kucharczyk T; Chmielewska I; Kieszko R; Jarosz B; Gil M; Reszka K; Milanowski J
Sci Rep; 2021 Oct; 11(1):20939. PubMed ID: 34686712
[TBL] [Abstract] [Full Text] [Related]
8. [Molecular genotyping in refractory thyroid cancers in 2021: When, how and why? A review from the TUTHYREF network].
de la Fouchardière C; Wassermann J; Calcagno F; Bardet S; Al Ghuzlan A; Borget I; Borson Chazot F; Do Cao C; Buffet C; Zerdoud S; Decaussin-Petrucci M; Godbert Y; Leboulleux S
Bull Cancer; 2021 Nov; 108(11):1044-1056. PubMed ID: 34593218
[TBL] [Abstract] [Full Text] [Related]
9. ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations.
Debonis SA; Bongiovanni A; Pieri F; Fausti V; De Vita A; Riva N; Gurrieri L; Vanni S; Diano D; Mercatali L; Ibrahim T
Medicine (Baltimore); 2021 May; 100(20):e25972. PubMed ID: 34011083
[TBL] [Abstract] [Full Text] [Related]
10. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy.
Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S
J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592
[TBL] [Abstract] [Full Text] [Related]
11. Molecular diagnosis in non-small-cell lung cancer: expert opinion on
Conde E; Rojo F; Gómez J; Enguita AB; Abdulkader I; González A; Lozano D; Mancheño N; Salas C; Salido M; Salido-Ruiz E; de Álava E
J Clin Pathol; 2022 Mar; 75(3):145-153. PubMed ID: 33875457
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.
Bardet S; Goardon N; Lequesne J; Vaur D; Ciappuccini R; Leconte A; Monpeyssen H; Saguet-Rysanek V; Clarisse B; Lasne-Cardon A; Ménégaux F; Leenhardt L; Buffet C
Endocrine; 2021 Feb; 71(2):407-417. PubMed ID: 32638211
[TBL] [Abstract] [Full Text] [Related]
13. [Gene Fusions as Acquired Resistance Mechanisms of EGFR-TKI].
Shao Y; Zhong D
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):381-387. PubMed ID: 32429639
[TBL] [Abstract] [Full Text] [Related]
14. Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.
Mack PC; Banks KC; Espenschied CR; Burich RA; Zill OA; Lee CE; Riess JW; Mortimer SA; Talasaz A; Lanman RB; Gandara DR
Cancer; 2020 Jul; 126(14):3219-3228. PubMed ID: 32365229
[TBL] [Abstract] [Full Text] [Related]
15. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-ret fusion.
Cheek EH; Fadra N; Jackson RA; Davila JI; Sukov WR; Uckerman MT; Clayton A; Keeney GL; Halling KC; Torres-Mora J; Schoolmeester JK
Hum Pathol; 2020 Mar; 97():29-39. PubMed ID: 31917155
[TBL] [Abstract] [Full Text] [Related]
16. Performance of Oncomine Fusion Transcript kit for formalin-fixed, paraffin-embedded lung cancer specimens.
Sakai K; Ohira T; Matsubayashi J; Yoneshige A; Ito A; Mitsudomi T; Nagao T; Iwamatsu E; Katayama J; Ikeda N; Nishio K
Cancer Sci; 2019 Jun; 110(6):2044-2049. PubMed ID: 30972901
[TBL] [Abstract] [Full Text] [Related]
17. Lung cancer family history and exposure to occupational/domestic coal combustion contribute to variations in clinicopathologic features and gene fusion patterns in non-small cell lung cancer.
Chen Y; Li G; Lei Y; Yang K; Niu H; Zhao J; He R; Ning H; Huang Q; Zhou Q; Huang Y
Thorac Cancer; 2019 Apr; 10(4):695-707. PubMed ID: 30775858
[TBL] [Abstract] [Full Text] [Related]
18. Population-level effect of molecular testing and targeted therapy in patients with advanced pulmonary adenocarcinoma: a prospective cohort study.
Schwegler C; Kaufmann D; Pfeiffer D; Aebi S; Diebold J; Gautschi O
Virchows Arch; 2018 Apr; 472(4):581-588. PubMed ID: 29198034
[TBL] [Abstract] [Full Text] [Related]
19.
Bastos AU; de Jesus AC; Cerutti JM
Eur J Endocrinol; 2018 Jan; 178(1):83-91. PubMed ID: 29046324
[TBL] [Abstract] [Full Text] [Related]
20. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1.
Haimes JD; Stewart CJR; Kudlow BA; Culver BP; Meng B; Koay E; Whitehouse A; Cope N; Lee JC; Ng T; McCluggage WG; Lee CH
Am J Surg Pathol; 2017 Jun; 41(6):773-780. PubMed ID: 28490045
[TBL] [Abstract] [Full Text] [Related]
[Next]
